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IntRoductIon
Radiation therapy (RT) is a well-established thera-
peutic modality in oncology and can serve as first line
as well as palliative therapy for many cancer types
such as lung cancer. Worldwide, lung cancer is one
of the most common cancer types and counts for about
18% of all cancer related deaths.1
Additionally, cancer patients may suffer from other
ailments, such as cardiac rhythm disturbances. The
severity of cardiac rhythm abnormalities may constitute
an indication for the implantation of either a perma-
nent pacemaker (PPM) or an implantable cardioverter
defibrillator (ICD).2 ICDs are devices that function
as pacemakers and have the ability of producing a
high voltage shock to the heart in order to potentially
terminate lethal cardiac arrhythmias. The ionizing
radiation of RT can interfere with the circuits of ICDs
resulting in potentially life-threatening malfunction.3
Guidelines for the management of patients with ICD
regarding RT are occasionally inconsistent and/or in-
explicit.4
In this case we present the therapeutic manage-
ment of a patient who underwent palliative radiation
therapy for lung cancer and carries an ICD, according
to the published recommendations for the irradiation
of ICDs.
cAse pResentAtIon
A 75 year-old man was referred to our hospital with
reported daily presence of bloody sputum for the last
3 months. His medical history revealed COPD, severe
heart failure and atrial fibrillation, and because he
fulfilled the indications he carried an ICD. The patient
underwent a chest X-ray (figure 1) and a chest CT
where a mass lesion was found in the right pulmonary
hilum with intense homogeneous enrichment after
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intravenous administration of a contrast agent. The
lesion was observed under the keel and posterior of
the trachea along with a nodal block. Due to the known
heart failure it was decided not to perform broncho -
scopy for biopsy and the exclusion of chemotherapy
as a therapeutic option. For these reasons the patient
was referred to the department of radiation oncology
for palliative-haemostatic RT.
The main problem that arose in this particular pa-
tient was that he carried an ICD. This had to be taken
into consideration during the planning of any RT ses-
sions concerning the path the external beams would
take and the total radiation volume.   Therefore, we
contacted the manufacturing company of the ICD
and after a literature review of similar cases, we man-
aged to perform RT without any adverse effects.
According to the safety precautions of in vivo and
in vitro studies about the irradiation of the ICDs, we
reached the following: 
1. PPMs and ICDs should not be placed in the direct
therapy beam. The radiation dose can be reduced
to such devices by maximizing the distance from
the device to the radiation fields. This can be done
by adjusting field shapes and directions, or by phys-
ically moving the device within the patient if nec-
essary. Ideally, the device should be kept 3 cm from
the edge of the unblocked machine collimator.5
2. After confirming that the device is located at a safe
distance from the source of radiation, shielding
can also be considered as an additional protection.
3. If the total dose exceeds 2 Gy, the devices should
be checked prior to therapy and possibly at start
of each radiation session.3
4. High-energy (>10 MV) photon beams should be
avoided.
We took into consideration all the safety precau-
tions and the fact that it was a palliative therapy and
the patient underwent 10 sessions of RT with a daily
dose of 3 Gy and a total dose of 30 Gy. We used mul-
tiple fields (figure 2) to access the planning tumor
volume (PTV), without exceeding the daily and total
acceptable dose of the ICD. The observation of the
Dose- Volume Histogram (DVH) (figure 3) shows
that all the critical structures receive safe dose ac-
cording to international guidelines. Every day before
the beginning of the RT session, a technician special-
ized in this field deactivated the ICD, and after the
end of the session he turned it back on again. 
The RT sessions were uneventful. The hemoptysis
stopped and the patient was visibly in a better condi-
Figure 3. Dose- Volume Histogram (DVH): planning tar-
get volume- red, heart- pink, left lung- orange, ICD- pur-
ple, ICD and electrode wires-green.
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Figure 1. Chest X-Ray showing the implantable 
cardioverter defibrillator.
Figure 2. Multiple fields’ technique to access the PTV,
without insetting the ICD directly to the therapy beams. 
tion. Recent follow-up of the patient at 6 months post
external beam radiation therapy revealed a normally
functioning device with no indications for concern a-
long with a small reduction of the mass. Further ther-
apy is not possible to be administered. 
dIscussIon
The increasing human life span and the development
of technology over the last decades came along with
an increase in the number of PPM and ICD implan-
tations worldwide. Considering the risk factors, that
are similar between heart disease and cancer, several
patients suffering from both conditions present for
RT treatment each year.
No uniform guidelines exist until now regarding
safe maximum cumulative radiation dose for ICDs.
In 1994, the American Association of Physicists in
Medicine produced guidelines for the management
of these patients, which have since been adopted by
many radiation- oncology departments internationally.6
Since then, there have been significant advances in
PPM and ICD technology and clinical practice should
change accordingly.7 The differences between models
and manufacturers also contribute to the difficulty of
producing universal guidelines and treating all the
patients the same.
All previous studies in the field of RT and ICDs
showed that radiation induced device malfunction is
rare, and death associated with that malfunction even
more uncommon.8 Apart from the immediate mal-
function of the device, there is also the possibility of
delayed effects, although, no such evidence exist thus
far.7
The management of patients with ICDs receiving
RT varies. The approach of every patient should be
indivi dualized and a great deal of thought and planning
should be given before the beginning of RT. A better
understanding of the effects, both immediate and late,
of RT on these devices will simplify management and
avoid unnecessary procedures. Therefore more in-
depth studies need to be conducted on the effect of
radiation on PPMs and ICDs.
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Εξωτερική ακτινοθεραπεία θώρακος σε ασθενή με καρδιακό απινιδωτή.
Μέμτσα Πηνελόπη- Θεοπίστη1, Λόγα Κωνσταντία2, Κυριακογιαννάκη Αριάδνη3,
Τζιτζίκας Ιωάννης1, Πιστεύου-Γομπάκη Κυριακή1
ΠΕΡΙληψη: Ένας μεγάλος αριθμός των ασθενών που πάσχουν από καρκίνο και χρήζουν αντιμετώπισης με ακτινο -
θεραπεία υποφέρουν από διάφορα συνοδά νοσή ματα. Μία πολύ συχνή περίπτωση είναι η συνοσηρότητα με καρδιακή αρ-
ρυθμία, η οποία σε πολλές περιπτώσεις απαιτεί την χρήση εμφυτεύσιμου καρδιακού απινιδωτή ή μόνιμου βηματοδότη. Η
λειτουργία των ηλεκτρονικών εμφυτεύσιμων συσκευών μπορεί να επηρεαστεί από τις ιοντίζουσες ακτινοβολίες που χρη-
σιμοποιούνται κατά την ακτινοθεραπεία. Για το λόγο αυτό, ειδικές παράμετροι πρέπει να λαμβάνονται υπ όψιν ώστε να
χορηγηθεί η ακτινοθεραπεία με ασφάλεια για τον ασθενή. Σε αυτό το άρθρο παρουσιάζουμε τη θεραπευτική αντιμετώπιση
ενός ασθενούς πάσχων από καρκίνο πνεύμονα ο οποίος έχρηζε παρηγορητικής θεραπείας με ακτινοθεραπεία και ταυτόχρονα
έφερε και εμφυτεύσιμο καρδιακό απινιδωτή.
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